Stockscreener 앱 받기
14.37
0.35%
0.05
시간 외 거래:
14.38
0.01
+0.07%
Lyell Immunopharma Inc 주식(LYEL)의 최신 뉴스
Lyell Immunopharma stock holds steady as investors await fresh clinical and cash-flow signals - AD HOC NEWS
This Insider Has Just Sold Shares In Lyell Immunopharma - simplywall.st
Lyell Immunopharma (LYEL) CEO sells shares for taxes, keeps 63,899 - Stock Titan
Lyell (LYEL) Outlook: Closes 4.57% Lower at $14.82 in the Latest Session; Next Session: the $14.08 to $15.56 Range Remains in Focus at the ClosePassive Flow - vinanet.vn
Lyell Immunopharma (LYEL): Foresite funds and Tananbaum report 2.7% ownership - Stock Titan
Citizens reiterates Lyell Immunopharma stock rating on pipeline progress By Investing.com - Investing.com Canada
Lyell Immunopharma, Inc. (NASDAQ:LYEL) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Lyell Immunopharma (LYEL) Slides 4.77% to $14.17 as Biotech Risk Appetite FadesTriple Top - dars.gov.et
Lyell Immunopharma VP Bulis sells $8,905 of common stock By Investing.com - Investing.com UK
Lyell Immunopharma VP Veronica Sanchez Bulis Sells 621 Shares for Tax Withholding on August 10, 2026 - Kalkine Media
Lyell Immunopharma COO Stephen J. Hill Sells Shares to Cover Tax Withholding on RSU Settlement - Kalkine Media
Lyell Immunopharma (LYEL) CSO auto-sells shares to cover RSU tax withholding - Stock Titan
Lyell Immunopharma VP Bulis sells $8,905 of common stock - Investing.com
Lyell Immunopharma CSO Executes Automatic Stock Sale to Meet Tax Withholding Requirements - Kalkine Media
Lyell Immunopharma (LYEL) VP auto-sells 621 shares to cover RSU taxes - Stock Titan
Lyell Immunopharma (LYEL) COO auto-sells 89 shares for RSU tax withholding - Stock Titan
Lyell Immunopharma (LYEL) CEO sells shares to cover RSU tax withholding - Stock Titan
Renaissance Technologies LLC Buys 76,921 Shares of Lyell Immunopharma, Inc. $LYEL - MarketBeat
Lyell Immunopharma, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Lyell Immunopharma earnings beat by $0.22, revenue fell short of estimates - Investing.com Canada
Possible Signal As Lyell Immunopharma Insiders Sell US$527k In Stock - webull.com
Lyell Immunopharma (NASDAQ:LYEL) Posts Earnings Results, Beats Expectations By $0.10 EPS - MarketBeat
Lyell Immunopharma, Inc. expected to post a loss of $2.08 a shareEarnings Preview - TradingView
Lyell Immunopharma: Q2 Earnings Snapshot - AOL.com
Lyell Immunopharma reports Q2 2026 net loss $44.8M, cash $228.0M; clinical milestones advance - TradingView
Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2026 - manilatimes.net
BRIEF-Lyell Immunopharma Q2 Operating Expenses USD 47.341 Million - TradingView
This Lyell Immunopharma Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Thursday - Benzinga
Lyell Immunopharma (NASDAQ:LYEL) Earns Buy Rating from Analysts at Stifel Nicolaus - MarketBeat
Stifel Initiates Lyell Immunopharma(LYEL.US) With Buy Rating, Announces Target Price $36 - Moomoo
LYELL IMMUNOPHARMA, INC. : STIFEL INITIATES COVERAGE WITH BUY RATING; TARGET PRICE $36 - Bitget
Stifel initiates Lyell Immunopharma stock with buy rating on CAR T therapy - Investing.com South Africa
LYEL Q2'26 Earnings: revenue estimate is 4.60K USD - TradingView
Lyell Immunopharma (LYEL) Projected to Post Quarterly Earnings on Tuesday - MarketBeat
Price to book forward of Lyell Immunopharma, Inc. – NASDAQ:LYEL - TradingView
Form 4 Lyell Immunopharma Inc For: 27 July By Investing.com - Investing.com Nigeria
Lyell Immunopharma, Inc. (LYEL) holder pays broker with 44,000 shares - Stock Titan
Broker commission transfer of 38,500 shares in Lyell Immunopharma (LYEL) - Stock Titan
Lyell Immunopharma Inc (LYEL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Lyell Immunopharma Inc (LYEL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Lyell Immunopharma Inc (LYEL) Cash Flow - TradingKey
Lyell Immunopharma Inc (LYEL) Institutional Confidence - TradingKey
Lyell Immunopharma Inc (LYEL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
LYEL|Lyell Immunopharma Inc|Price:12.950|Chg%:+0.320 - TradingKey
TradingKey - TradingKey
Lyell Immunopharma Inc (LYEL) Balance Sheet - TradingKey
LYEL|Lyell Immunopharma Inc|Price:12.615|Chg%:-0.165 - TradingKey
Lyell Immunopharma, Inc. Revenue Breakdown – NASDAQ:LYEL - TradingView
Lyell Immunopharma Inc (LYEL) Valuation: PE, PB & Fair Value Analysis - TradingKey
Lyell Immunopharma Inc (LYEL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
B. Riley Securities Initiates Lyell Immunopharma(LYEL.US) With Buy Rating, Announces Target Price $44 - Moomoo
LYEL Initiates Coverage by B. Riley Securities -- Price Target A - GuruFocus
Stifel initiates Lyell Immunopharma stock with buy, $44 target - Investing.com India
Lyell Immunopharma, Inc. SEC Filing (Jul 22, 2026) - Stock Titan
Stifel initiates Lyell Immunopharma stock with buy, $44 target By Investing.com - Investing.com Canada
0.86%
0.31%
자본화:
|
볼륨(24시간):